Guardado en:
| Autor principal: | Harrouche, Oussama |
|---|---|
| Formato: | Recurso digital |
| Lenguaje: | |
| Publicado: |
Zenodo
2025
|
| Acceso en línea: | https://doi.org/10.5281/zenodo.14919603 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
GPCR‐G protein selectivity revealed by structural pharmacology
por: Sarah M. Bernhard, et al.
Publicado: (2024)
por: Sarah M. Bernhard, et al.
Publicado: (2024)
GPCR dimerization: Drug discovery aspects and targets in renin‐angiotensin systems
por: Tahmid Faisal, et al.
Publicado: (2025)
por: Tahmid Faisal, et al.
Publicado: (2025)
Kinase targeting in Luminal B breast cancer: CDK5.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Unlocking mitochondrial drug targets: The importance of mitochondrial transport proteins
por: Charlotte A. Hoogstraten, et al.
Publicado: (2024)
por: Charlotte A. Hoogstraten, et al.
Publicado: (2024)
Therapeutic targeting in breast cancer for the treatment of lung metastasis: CDK7.
por: Mamoor, Shahan
Publicado: (2025)
por: Mamoor, Shahan
Publicado: (2025)
Relevance of G protein‐coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation
por: Marta Lopez‐Balastegui, et al.
Publicado: (2024)
por: Marta Lopez‐Balastegui, et al.
Publicado: (2024)
Input files, parameters, and scripts used for the computational mapping and targeting of BK channel protein–protein interactions in breast cancer
por: Vergara-Jaque, Ariela, et al.
Publicado: (2026)
por: Vergara-Jaque, Ariela, et al.
Publicado: (2026)
Engineering IGF2 for Lysosome‐targeting chimeras development to target drug‐resistant membrane proteins in tumor therapy
por: Yanchao Pan, et al.
Publicado: (2025)
por: Yanchao Pan, et al.
Publicado: (2025)
Discovering new mode‐of‐action pesticide leads inhibiting protein–protein interactions: example targeting plant O ‐acetylserine sulfhydrylase
por: Rotem Shelly Ben‐Shushan, et al.
Publicado: (2024)
por: Rotem Shelly Ben‐Shushan, et al.
Publicado: (2024)
GPCR-Filter: a deep learning framework for efficient and precise GPCR modulator discovery
por: Ning, Jingjie, et al.
Publicado: (2026)
por: Ning, Jingjie, et al.
Publicado: (2026)
ApexGen: Simultaneous design of peptide binder sequence and structure for target proteins
por: Xia, Xiaoqiong, et al.
Publicado: (2025)
por: Xia, Xiaoqiong, et al.
Publicado: (2025)
Unlocking GPCR–ligand interactions: Measuring binding affinities with thermal shift assay
por: Dmitrii Dashevskii, et al.
Publicado: (2025)
por: Dmitrii Dashevskii, et al.
Publicado: (2025)
Heterogeneous networks in drug-target interaction prediction
por: Molaee, Mohammad, et al.
Publicado: (2025)
por: Molaee, Mohammad, et al.
Publicado: (2025)
CDK6 protein expression is associated with disease progression and treatment resistance in multiple myeloma
por: Johannes Steinhart, et al.
Publicado: (2024)
por: Johannes Steinhart, et al.
Publicado: (2024)
Development of tau targeted protein degraders for Alzheimer disease
por: Lisha Wang, et al.
Publicado: (2024)
por: Lisha Wang, et al.
Publicado: (2024)
Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
por: Mamoor, Shahan
Publicado: (2026)
por: Mamoor, Shahan
Publicado: (2026)
Lysosome‐targeting chimera (LYTAC): A silver bullet for targeted degradation of oncogenic membrane proteins
por: Qingquan Zheng, et al.
Publicado: (2024)
por: Qingquan Zheng, et al.
Publicado: (2024)
Mechanisms governing GPCR anterograde transport
por: Kevin Assoumou, et al.
Publicado: (2025)
por: Kevin Assoumou, et al.
Publicado: (2025)
GPCR microswitch analysis scripts and data
por: Ji, Jingjing, et al.
Publicado: (2026)
por: Ji, Jingjing, et al.
Publicado: (2026)
Privileged proteins with a second residence: dual targeting and conditional re‐routing of mitochondrial proteins
por: Ophry Pines, et al.
Publicado: (2024)
por: Ophry Pines, et al.
Publicado: (2024)
Sequence-based protein-protein interaction prediction and its applications in drug discovery
por: Charih, François, et al.
Publicado: (2025)
por: Charih, François, et al.
Publicado: (2025)
Glycopolymers stabilize protein folding and protein–protein interactions via enthalpic interactions
por: Sabrina M. Richter, et al.
Publicado: (2025)
por: Sabrina M. Richter, et al.
Publicado: (2025)
Computational modeling and experimental validation of the interaction between tumor biomarker mesothelin and an engineered targeting protein with therapeutic activity
por: Margherita Piccardi, et al.
Publicado: (2025)
por: Margherita Piccardi, et al.
Publicado: (2025)
Utilizing aptamers in targeted protein degradation strategies for disease therapy
por: Lin Li, et al.
Publicado: (2025)
por: Lin Li, et al.
Publicado: (2025)
Theranostics targeting fibroblast activation protein in the pan‐cancer field
por: Yutao Li, et al.
Publicado: (2025)
por: Yutao Li, et al.
Publicado: (2025)
Redirecting TRIM21 with TRIMTACs for the targeted degradation of multimeric proteins
por: Marc A. Scemama de Gialluly, et al.
Publicado: (2026)
por: Marc A. Scemama de Gialluly, et al.
Publicado: (2026)
Construction of a versatile fusion protein for targeted therapy and immunotherapy
por: Xiu‐Song Huang, et al.
Publicado: (2024)
por: Xiu‐Song Huang, et al.
Publicado: (2024)
The emerging role of targeted protein degradation to treat and study cancer
por: Maximillian H Brodermann, et al.
Publicado: (2024)
por: Maximillian H Brodermann, et al.
Publicado: (2024)
The contribution of mRNA targeting to spatial protein localization in bacteria
por: Wenkang Shang, et al.
Publicado: (2024)
por: Wenkang Shang, et al.
Publicado: (2024)
Design, synthesis, and analysis of macrobicyclic peptides for targeting the Gαi protein
por: Anna Pepanian, et al.
Publicado: (2024)
por: Anna Pepanian, et al.
Publicado: (2024)
De novo design of protein binders targeting the human sweet taste receptor as potential sweet proteins
por: Ding, Saisai, et al.
Publicado: (2026)
por: Ding, Saisai, et al.
Publicado: (2026)
Structuring the GPCR Story Through the Lens of NMR
por: Arpita Prasad, et al.
Publicado: (2025)
por: Arpita Prasad, et al.
Publicado: (2025)
The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma
por: Ana B. Caniceiro, et al.
Publicado: (2026)
por: Ana B. Caniceiro, et al.
Publicado: (2026)
Artificial intelligence streamlines scientific discovery of drug–target interactions
por: Yuxin Yang, et al.
Publicado: (2025)
por: Yuxin Yang, et al.
Publicado: (2025)
A large dataset curation and benchmark for drug target interaction
por: Golts, Alex, et al.
Publicado: (2024)
por: Golts, Alex, et al.
Publicado: (2024)
The unfolded protein response is a potential therapeutic target in pathogenic fungi
por: Hao Zhou, et al.
Publicado: (2025)
por: Hao Zhou, et al.
Publicado: (2025)
Heat shock protein 90: biological functions, diseases, and therapeutic targets
por: Huiyun Wei, et al.
Publicado: (2024)
por: Huiyun Wei, et al.
Publicado: (2024)
Mapping protein–protein interactions by mass spectrometry
por: Xiaonan Liu, et al.
Publicado: (2024)
por: Xiaonan Liu, et al.
Publicado: (2024)
AI for plant protein–protein interactions prediction
por: Rui Deng, et al.
Publicado: (2026)
por: Rui Deng, et al.
Publicado: (2026)
Progress on the development of Class A GPCR‐biased ligands
por: Paula Morales, et al.
Publicado: (2024)
por: Paula Morales, et al.
Publicado: (2024)
Ejemplares similares
-
GPCR‐G protein selectivity revealed by structural pharmacology
por: Sarah M. Bernhard, et al.
Publicado: (2024) -
GPCR dimerization: Drug discovery aspects and targets in renin‐angiotensin systems
por: Tahmid Faisal, et al.
Publicado: (2025) -
Kinase targeting in Luminal B breast cancer: CDK5.
por: Mamoor, Shahan
Publicado: (2025) -
Unlocking mitochondrial drug targets: The importance of mitochondrial transport proteins
por: Charlotte A. Hoogstraten, et al.
Publicado: (2024) -
Therapeutic targeting in breast cancer for the treatment of lung metastasis: CDK7.
por: Mamoor, Shahan
Publicado: (2025)